The US Food and Drug Administration has approved VYALEV, a groundbreaking therapy developed by AbbVie to treat adults with ...

AbbVie announced that the US Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for the ...

The U.S. FDA has approved the first 24-hour continuous subcutaneous infusion for adults with advanced Parkinson’s disease.

Natalia Morari once reported on corrupt business in Moldova. Now she has upset many by having a son with a tycoon accused of corruption, and running against the pro-West president in elections ...

ABC NEWS features continuous, commercial-free coverage of major breaking stories in Australia and around the world. Watch all your favourite ABC programs on ABC iview. More from ABC We acknowledge ...